SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-004479
Filing Date
2017-04-27
Accepted
2017-04-27 17:00:21
Documents
6
Period of Report
2017-04-27
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 616850
2 image_001.jpg GRAPHIC 11813
3 image_002.jpg GRAPHIC 12468
4 image_003.jpg GRAPHIC 12320
5 image_010.jpg GRAPHIC 102712
6 image_011.jpg GRAPHIC 107084
  Complete submission text file 0001493152-17-004479.txt   958027
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35814 | Film No.: 17790033
SIC: 2834 Pharmaceutical Preparations